You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Previously%20treated%20Small%20Lymphocytic%20Lymphoma%20(SLL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

Not yet recruiting
  • B-cell Malignancy
  • +7 more
  • (no location specified)
Oct 26, 2022

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Not yet recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

CLL/SLL, NHL Trial in China (BN102)

Not yet recruiting
  • CLL/SLL
  • NHL
  • Guangzhou, China
  • +5 more
May 4, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
Mar 16, 2022

CLL/SLL, NHL, MCL Trial in United States (HMPL-760)

Recruiting
  • CLL/SLL
  • +8 more
  • Atlanta, Georgia
  • +3 more
Feb 24, 2022

Chronic Lymphocytic Leukemia, CLL, SLL Trial in United States (TP-0903, TP-0903 and ibrutinib combination therapy)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • TP-0903
  • TP-0903 and ibrutinib combination therapy
  • Phoenix, Arizona
  • +5 more
Apr 4, 2022

Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell Trial in China (LOXO-305)

Active, not recruiting
  • Leukemia, Lymphoid
  • +6 more
  • Wuhu, Anhui, China
  • +22 more
Dec 8, 2022

Lymphocytic Leukemia, Chronic, Lymphoma, Small Lymphocytic Trial in Canada, United States (IPI-145 (duvelisib), Obinutuzumab)

Terminated
  • Lymphocytic Leukemia, Chronic
  • Lymphoma, Small Lymphocytic
  • La Jolla, California
  • +6 more
Mar 15, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Duvelisib)

Withdrawn
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Tempe, Arizona
  • +7 more
Mar 15, 2021

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

Orelabrutinib in the Treatment of CLL/SLL

Not yet recruiting
  • CLL/SLL
    • (no location specified)
    Jul 26, 2023

    Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)

    Active, not recruiting
    • Leukemia
    • Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Oct 11, 2022

    Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) Trial run by the National Heart, Lung, and Blood Institute

    Active, not recruiting
    Has Results
    • Small Lymphocytic Lymphoma
    • CLL (Chronic Lymphocytic Leukemia)
    • Fludarabine Phosphate
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 13, 2022

    Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

    Completed
    • Lymphoid Leukemia
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin
    Jan 30, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Leukemia
    • (no location specified)
    Nov 30, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • (no location specified)
    Nov 22, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

    Not yet recruiting
    • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
      • (no location specified)
      Dec 16, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • TQB3909 tablet
      • Zhengzhou, Henan, China
      • +1 more
      Jul 17, 2023

      Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

      Not yet recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • +5 more
      • (no location specified)
      Jul 21, 2023

      Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

      Terminated
      Has Results
      • Small Lymphocytic Leukemia (SLL)
      • Chronic Lymphocytic Leukemia (CLL)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 15, 2022

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Rochester (Acalabrutinib, Rituximab)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • Small Lymphocytic Lymphoma (SLL)
      • Rochester, New York
        University of Rochester
      Feb 7, 2022

      Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small

      Recruiting
      • CLL/SLL
      • Jinan, Shandong, China
        Department of Hematology, Shandong Provincial Hospital Affiliate
      Jun 16, 2023

      Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide

      Completed
      Has Results
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • +2 more
      • Tafasitamab
      • +2 more
      • Jacksonville, Florida
      • +16 more
      Dec 10, 2021

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

      Active, not recruiting
      Has Results
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Acalabrutinib (Arm A)
      • Acalabrutinib (Arm B)
      • Bethesda, Maryland
        Research Site
      Jan 3, 2023